Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

The Human Cytomegalovirus Protein UL37 Exon 1 Associates with Internal Lipid Rafts

Chad D. Williamson, Aiping Zhang, Anamaris M. Colberg-Poley
Chad D. Williamson
1Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010
2Biochemistry and Molecular Genetics Program, George Washington University School of Medicine and Health Sciences, Washington, DC 20037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aiping Zhang
1Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anamaris M. Colberg-Poley
1Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010
2Biochemistry and Molecular Genetics Program, George Washington University School of Medicine and Health Sciences, Washington, DC 20037
3Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC 20037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: acolberg-poley@cnmcresearch.org
DOI: 10.1128/JVI.01830-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The human cytomegalovirus (HCMV) protein UL37 exon 1 (pUL37x1), also known as viral mitochondrion-localized inhibitor of apoptosis (vMIA), sequentially traffics from the endoplasmic reticulum (ER) through mitochondrion-associated membranes (MAMs) to the outer mitochondrial membrane (OMM), where it robustly inhibits apoptosis. Here, we report the association of pUL37x1/vMIA with internal lipid rafts (LRs) in the ER/MAM. The MAM, which serves as a site for lipid transfer and calcium signaling to mitochondria, is enriched in detergent-resistant membrane (DRM)-forming lipids, including cholesterol and ceramide, which are found in lower concentrations in the bulk ER. Sigma 1 receptor (Sig-1R), a MAM chaperone affecting calcium signaling to mitochondria, is anchored in the MAM by its LR association. Because of its trafficking through the MAM and partial colocalization with Sig-1R, we tested whether pUL37x1/vMIA associates with MAM LRs. Extraction with methyl-β-cyclodextrin (MβCD) removed pUL37x1/vMIA from lysed but not intact cells, indicating its association with internal LRs. Furthermore, the isolation of DRMs from purified intracellular organelles independently verified the localization of pUL37x1/vMIA within ER/MAM LRs. However, pUL37x1/vMIA was not detected in DRMs from mitochondria. pUL37x1/vMIA associated with LRs during all temporal phases of HCMV infection, indicating the likely importance of this location for HCMV growth. Although detected during its sequential trafficking to the OMM, the pUL37x1/vMIA LR association was independent of its mitochondrial targeting signals. Rather, it was dependent upon cholesterol binding. These studies suggest a conserved ability of UL37 proteins to interact with cholesterol and LRs, which is functionally distinguishable from their sequential trafficking to mitochondria.

Human cytomegalovirus (CMV) (HCMV) is a medically important herpesvirus which causes serious diseases in congenitally infected infants and in immunocompromised individuals (54). To extend cell survival during its protracted lytic replication, HCMV encodes several antiapoptotic products, including the UL37, UL36, UL38, and major immediate-early 1/2 (IE1/2) gene products (24, 25, 49, 77, 85, 93) as well as the β2.7 RNA, which inhibits proapoptotic signals from the mitochondrial GRIM complex (66).

The HCMV UL37 IE product, the UL37 exon 1 (UL37x1) protein (pUL37x1), also known as viral mitochondrion-localized inhibitor of apoptosis (vMIA), sequesters proapoptotic Bax at the outer mitochondrial membrane (OMM) and prevents cytochrome c release and the subsequent initiation of the proapoptotic cascade (3, 58, 60, 62). pUL37x1/vMIA also causes calcium (Ca2+) efflux from endoplasmic reticulum (ER) stores and F-actin cytoskeleton disruption, which results in early and late cytopathologies (63, 72). pUL37x1/vMIA also transactivates the expression of HCMV early genes whose products are required for its genome replication (5, 14, 67, 90). At late times of infection, pUL37x1/vMIA further extends cell viability by inhibiting a mitochondrial serine protease, HtrA2/Omi, that terminates infection (50).

pUL37x1/vMIA, the UL37 glycoprotein (gpUL37), and the UL37 medium isoform (pUL37M) share NH2-terminal UL37x1 sequences (25, 40). pUL37x1/vMIA is the predominant UL37 product during HCMV infection (45, 72). gpUL37 is lower in abundance and internally cleaved, generating pUL37NH2 and gpUL37COOH, which divergently traffic to the OMM and the secretory apparatus, respectively (2, 46, 47). pUL37x1/vMIA is essential for HCMV growth in humans (27) and for the growth of HCMV primary strains (37) and strain AD169 (19, 65, 72, 91) in cultured primary human foreskin fibroblasts (HFFs).

HCMV UL37 proteins are synthesized at the ER membrane and traffic from there to the OMM (2, 9, 25, 45, 47, 88). The sequential trafficking of HCMV UL37 proteins was demonstrated by the finding that a gpUL37 cleavage site mutant is first ER translocated, where it is N-glycosylated, and then imported into the OMM (46, 47). The UL37x1 mitochondrial targeting signal (MTS) (amino acids [aa] 1 to 34) (45, 88) comprises a subdomain that, combined with downstream sequences (aa 118 to 147), confers potent antiapoptotic activity (3, 25, 27, 51, 60, 62, 78). Defects in its ER-to-mitochondrion trafficking result in impaired pUL37x1/vMIA antiapoptotic functions (9, 27). HCMV viral mutants defective in UL37x1 antiapoptotic functions are also defective in growth (65, 72).

The pUL37x1/vMIA NH2-terminal MTS, including the low-hydropathy leader, a posttranslational modification site (21SY), and a downstream proline-rich domain (PRD), regulates ER translocation and mitochondrial import (45, 47, 88). During their trafficking to the OMM, HCMV UL37 proteins target the connections between the ER and mitochondria known as mitochondrion-associated membranes (MAMs) (9, 87). Targeting of the MAM, common to all studied HCMV UL37 isoforms, occurs continuously during infection (9, 10, 45, 47), suggesting its importance for HCMV growth.

Communication between the ER and mitochondria is important for bioenergetics and cell survival (31). The MAM regulates crucial aspects of this communication (29, 31, 82, 83). The MAM is an ER subdomain distinguishable from bulk ER in both lipid and protein contents, as it is enriched in chaperones and in lipid synthetic enzymes (31, 69, 73, 86). The MAM provides sites of transient contact between the ER and mitochondria (29, 81), partially mediated by GRP75 (82) and stabilized by the ER sorting protein PACS-2 (74) and the mitochondrial shaping protein mitofusin 2 (Mfn2) (15, 16).

One major function of the MAM is to control mitochondrial Ca2+ signaling (61). Ca2+-handling proteins such as inositol 1,4,5-triphosphate receptor type 3 (IP3R3) are highly compartmentalized in the MAM (52). Ca2+ is released from the ER through IP3R3, which forms a macromolecular complex with cytosolic GRP75 and voltage-dependent anion channel 1 (VDAC1) of the OMM (82), generating high-Ca2+ microdomains between the ER and mitochondria. Sigma 1 receptor (Sig-1R), a ligand-operated chaperone in the MAM, stabilizes IP3R3 and prolongs Ca2+ signaling (29, 31). HCMV infection progressively increases levels of cytosolic GRP75 in the MAM (10), likely affecting ER-mitochondrial Ca2+ signaling through the action of pUL37x1/vMIA therein (72).

Sig-1R is localized within lipid rafts (LRs) and is anchored in the MAM by this association (28, 32). LRs are small membrane microdomains where functionally related signaling machineries are clustered (48, 56). The MAM is a specialized ER subdomain known to accommodate internal LRs, experimentally defined as detergent-resistant membranes (DRMs) enriched in Sig-1R (28, 32, 33). MAM LRs, which can be demarcated by Sig-1R using confocal microscopy, appear as disc-like integral membrane accumulations of neutral lipids that remain discrete from the soluble, cytosolic lipid droplets capable of peripherally tethering to ER membranes (32). A portion of pUL37x1/vMIA is found in close proximity to Sig-1R-yellow fluorescent protein (YFP) (87). Because of its MAM localization, its partial colocalization with Sig-1R (9, 87), and the presence of Sig-1R in MAM LRs, we tested whether HCMV pUL37x1/vMIA associates with internal LRs. We found that HCMV pUL37x1/vMIA associates with internal LRs in transfected and in HCMV-infected cells during all temporal phases of infection. Surprisingly, we found that the pUL37x1/vMIA LR association does not dictate its trafficking but rather that its LR association is cholesterol dependent.

(These studies were in part performed by C.D.W. in fulfillment of his doctoral studies in the Biochemistry and Molecular Genetics Program at the George Washington Institute of Biomedical Sciences.)

MATERIALS AND METHODS

Cells and viruses.HeLa cells and HFFs (Viromed) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS; HyClone), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (1). The HCMV bacterial artificial chromosome strain AD169 (BAD) wild type (wt) (BADwt) was grown as previously described (72). Life-extended HFFs (LE-HFFs) were uninfected or infected with BADwt at a multiplicity of infection (MOI) of 3.

Mutagenesis.Site-specific mutations were introduced into the UL37 open reading frame (ORF) by site-directed mutagenesis using QuikChange kits (Stratagene) according to the manufacturer's instructions. To generate the CBD I (Y19S) mutation in the UL37x1 leader (CBD I1-36, p1481) and the full-length pUL37x1 ORF (CBD I1-163, p1515), forward primer 583 (5′-CTGCTGGCCTTTTGGTCCTTTAGCTACCGCTGG-3′) and reverse primer 584 (5′-CCAGCGGTAGCTAAAGGACCAAAAGGCCAGCAG-3′) were used. To generate CBD II (Y19S and R23A) in the UL37x1 leader sequence (CBD II1-36, p1483) and in the full-length UL37x1 ORF (CBD II1-163, p1521 and p1522), forward primer 587 (5′-CCTTTTGGTCCTTTAGCTACGCCTGGATCCAGCGAAAAC-3′) and reverse primer 588 (5′-GTTTTCGCTGGATCCAGGCGTAGCTAAAGGACCAAAAGG) were used to amplify the corresponding CBD I mutant plasmids (p1481 or p1515).

Transient transfection.For the isolation of ER/MAM and mitochondria, HeLa cells (∼6 × 106 to 8 × 106 cells) were transfected by using Lipofectamine 2000 (Invitrogen) suspended in Optimem (Gibco) according to the manufacturer's protocols, as previously described (9, 47). Briefly, DNA (μg)-to-lipid (μl) ratios for transfection were 1:1.75, with ∼20 μg DNA and 35 μl Lipofectamine 2000 used per T175 flask. Twenty-four hours after transfection, adherent cells were harvested and either stored on ice for fractionation or stored at −80°C for subsequent fractionation as previously described (8, 9).

Subcellular fractionations.Protocols for subcellular fractionations were previously described (8, 9). Briefly, for ER/MAM and mitochondrial fractionations, pellets of transfected cells were resuspended in 2 ml of MTE buffer (270 mM mannitol, 10 mM Tris-HCl, 0.1 mM EDTA [pH 7.4]) supplemented with complete protease inhibitor cocktail (Roche) and 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma) and lysed by sonication (an output power of 3.5). Cellular debris and intact cells were removed by centrifugation at 700 × g for 10 min at 4°C. Crude mitochondria were pelleted by centrifugation at 15,000 × g for 10 min at 4°C, and the postmitochondrial supernatant was used for the purification of ER/MAM fractions. Purified mitochondria were obtained by banding in discontinuous sucrose gradients consisting of 1.0 M and 1.7 M sucrose steps in 10 mM Tris-HCl (pH 7.6) at 40,000 × g for 22 min at 4°C. Postmitochondrial supernatants were layered onto discontinuous sucrose gradients (1.3 M, 1.5 M, and 2.0 M sucrose in 10 mM Tris-HCl [pH 7]) and banded by centrifugation at 100,000 × g for 45 min at 4°C. The purified ER/MAM and mitochondrial pellets were resuspended in 1× phosphate-buffered saline (PBS) and stored at −20°C until use.

Protein concentration determination.Protein concentrations of isolated subcellular fractions were determined by using a BCA assay kit (Pierce) according to the manufacturer's recommendations.

Western analyses.Twenty micrograms of total lysate or subcellular fractions was separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) in 10% Bis-Tris NuPage gels (Invitrogen) and transferred onto nitrocellulose membranes in Tris-glycine buffer with 20% methanol (50 V for 60 min) as described previously (9, 47). The parental control, wt control, and the vector negative control were included in all experiments. Membranes were blocked for 2 h at room temperature (RT) in 1× PBS containing 5% milk powder (Carnation) and 0.1% Tween 20 (Sigma) and then probed with primary antibody for 1 h at RT in 1× PBS containing 1% bovine serum albumin (BSA; Sigma). Primary antibodies used for these studies include rabbit anti-pUL37x1/vMIA (DC35; 1:2,500) (47), mouse anti-green fluorescent protein (GFP) (1:200; Santa Cruz Biotechnology), mouse anti-GRP75 (1:1,000, Stressgen); rabbit anti-fatty acid coenzyme A (CoA) ligase 4 (FACL4) (1:250; Abgent), goat anti-dolichyl phosphate mannose synthase 1 (DPM1) (1:100; Santa Cruz), mouse anti-Sig-1R (1:200; Santa Cruz), rabbit anti-prohibitin, (1:200; GeneTex), rabbit anti-cholera toxin subunit B (CTB) (1:200; Molecular Probes), rabbit anti-DsRed (1:2,000; Clontech), rabbit anti-erlin 2 (1:500; a gift from Stephen Robbins), and mouse anti-Lyn (1:250; BD Biosciences) antibodies.

Horseradish peroxidase (HRP)-conjugated secondary antibodies (1:2,500; Santa Cruz) were incubated for 1 h at RT in 1× PBS with 1% (wt/vol) BSA. Protein bands were detected by using an ECL detection kit (Pierce). Each blot was then stripped in 62.5 mM Tris buffer containing 2% SDS and 100 mM 2-mercaptoethanol for 1 h at 50°C with shaking. Stripped blots were washed seven times with 1× PBS, blocked, and reprobed for the detection of the specific protein organelle markers. Digital images were generated by using Scan Wizard Pro, version 1.21, and processed with Adobe Photoshop CS3.

Indirect immunofluorescence assay (IFA).HFFs were seeded at 20 to 30% confluence (∼4 × 105 cells/cm2) on sterile coverslips in six-well plates (9.72 cm2 per well). Twenty-four hours later, cells were transiently transfected by using Lipofectamine 2000 suspended in Optimem according to the manufacturer's protocols. DNA (μg)-to-lipid (μl) ratios for transfection were 1:1.75, with approximately 0.5 μg total DNA used per cm2 of available plating surface area. Cells were fixed with ice-cold 100% methanol for 10 min. Fixed cells were washed with 1× PBS. Cells were then sequentially probed with primary antibodies as described previously (9, 13, 47).

Staining of lipid droplets.HFFs were transfected with expression vectors encoding Sig-1R-yellow fluorescent protein (YFP) or pUL37x1 wt1-163-YFP and fixed 24 h later with 4% paraformaldehyde in 1× PBS for 30 min. Fixed cells were washed 5 times with 1× PBS, permeabilized with 1× PBS plus 0.75% Triton X-100, and blocked for 45 min using 1× PBS plus 4% BSA. Cells were then rinsed twice for 5 min each in 100% propylene glycol, stained for 7 min in prewarmed 100% propylene glycol containing Oil Red O (0.5%) in a 60°C oven, and rinsed again once for 3 min in 85% propylene glycol. Cells were then washed twice with distilled water and imaged by using confocal microscopy.

Confocal microscopy.Images were acquired with a Zeiss LSM 510 confocal microscope (Intellectual and Developmental Disabilities Research Center) as described previously (9, 47, 87, 88). Excitation wavelengths for the Zeiss LSM 510 microscope were 488 nm (for GFP), 514 nm (for YFP; emission collected through a 530- to 600-nm filter), and 561 nm (for DsRed1-mito). Images were acquired by sequential excitation through a 63× (numerical aperture [NA], 1.4) objective. Postacquisition processing was performed by using Adobe Photoshop CS3.

MβCD extraction of pUL37x1/vMIA from intracellular LRs.HeLa cells were transfected with either pUL37x1 wt1-163-YFP or Sig-1R-YFP. Twenty-four hours later, transfected cells were incubated in 5% CO2 at 37°C for 2 h in HFF medium alone (control) or HFF medium supplemented with 20 mM methyl-β-cyclodextrin (MβCD) (Sigma). Cells were then harvested and fractionated to purify ER/MAM and mitochondrial fractions (8, 88). Alternatively, comparable sets of transfected cells were grown in HFF medium for 24 h, harvested, and then resuspended in MTE buffer alone (control) or MTE buffer supplemented with 20 mM MβCD. Cells were sonicated in the above-described buffer and incubated at 37°C for 1 h with shaking. Subsequently, all cell lysate suspensions were separately pelleted at 700 × g for 10 min at 4°C and resuspended in fresh MTE buffer lacking MβCD. Pellets were fractionated to isolate purified ER/MAM and mitochondrial fractions as previously described (8, 9). Finally, comparable sets of transfections were performed and allowed to grow in HFF medium alone for 24 h and then harvested and fractionated to isolate purified ER/MAM and mitochondrial fractions. These purified fractions were resuspended in 10 ml of 1× PBS alone (control) or 1× PBS supplemented with 20 mM MβCD and incubated at 37°C for 1 h with shaking. Fraction suspensions were pelleted (15,000 × g for 10 min at 4°C for mitochondrial fractions and 100,000 × g for 45 min at 4°C for ER/MAM fractions) and analyzed by Western blotting.

LR purification.LRs were isolated by purification on flotation sucrose gradients as previously described (12, 79). Briefly, transiently transfected HeLa cells (2 × 107 to 5 × 107 cells) or HFFs (6 × 107 fibroblasts) were harvested by scraping or trypsinization, resuspended in MBS buffer (25 mM 4-morpholineethanesulfonic acid and 150 mM sodium chloride [pH 6.5] containing a protein inhibitor cocktail [Roche] at 1 tablet/50 ml or 1 mM PMSF), lysed by Dounce homogenization and sonication (three 30-s bursts; Polytron), and treated with 1% Triton X-100 or 1% Triton X-114 (MBST buffer) on ice for 30 min. Following detergent treatment, permeabilized cell lysates were mixed 1:1 with a 90% sucrose solution and overlaid with discontinuous layers of 35% and 5% sucrose. Gradients were resolved by centrifugation in a Beckman SW41 rotor at 160,030 × g (36,000 rpm) for 18 h or at 187,813 × g (39,000 rpm) for16 h at 4°C. Twelve 1-ml fractions were sequentially collected starting from the top to the bottom of the tube after centrifugation. Aliquots of each fraction (20 to 30 μl) were separated by SDS-PAGE and Western blot analyses with antibodies as described above.

RESULTS

pUL37x1/vMIA intercalates into lipid-rich ER/MAM domains.To determine if pUL37x1/vMIA localizes to lipid-rich domains within intracellular ER/MAMs, similarly to Sig-1R, lipids were extracted from transfected HeLa cells transiently expressing pUL37x1 wt1-163-YFP using methanol (92) prior to subcellular fractionation (Fig. 1 A). Purified ER/MAM and mitochondrial organelles were banded in discontinuous sucrose gradients during fractionation and were subsequently examined for the presence of pUL37x1/vMIA by using Western analyses. The abundance of pUL37x1/vMIA was reduced substantially from ER/MAMs but not from mitochondrial membranes following methanol extraction. Controls included YFP-transfected cells and a known LR marker, Lyn, as well as MAM components, FACL4 and GRP75, a mitochondrial marker and a cytosolic component of the MAM junction complex, IP3R3-GRP75-VDAC (82). The extraction of pUL37x1/vMIA predominantly from the ER/MAM fraction suggests that pUL37x1/vMIA localizes to lipid-rich domains therein.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

(A) Methanol extraction of pUL37x1/vMIA from ER/MAMs but not mitochondrial membranes. HeLa cells were transfected with vectors expressing pUL37x1 wt1-163-YFP or YFP and harvested 24 h later. Cells were either treated with ice-cold methanol (+) or left on ice (−) for 10 min, prior to subcellular fractionation to purify ER/MAM and mitochondrial fractions as described previously (8, 9). Purified fractions (20 μg) were separated by SDS-PAGE and analyzed by Western analysis using anti-UL37x1 (DC35) (1:2,500), anti-FACL4 (1:250), anti-Lyn (1:250), or anti-GRP75 (1:1,000) antibodies. (B) pUL37x1/vMIA does not detectably localize to cytosolic lipid droplets. HFFs were transfected with expression vectors encoding pUL37x1 wt1-163-YFP or Sig-1R-YFP and harvested 24 h later. Fixed cells were permeabilized, stained with Oil Red O, and imaged for YFP (green) and Oil Red O (red) using confocal microscopy. The micrographs on the left and middle are grayscale, and that on the right is the color overlay. The boxes show enlargements of the regions of interest in the cells. (C) MβCD extraction of pUL37x1/vMIA from intracellular LRs. HeLa cells were transfected with either pUL37x1 wt1-163-YFP or Sig-1R-YFP expression vectors and harvested 24 h later. Cells were sonicated (lysed) or left intact (whole cells [WC]) and treated with 20 mM MβCD for 1 h at 37°C (11). MβCD-treated cells were fractionated to obtain ER/MAM and mitochondrial fractions as described previously (8, 9). Purified fractions (20 μg) were resolved by SDS-PAGE and subjected to Western analysis using anti-GFP/YFP (1:200), anti-DPM1 (1:100), anti-FACL4 (1:250), or anti-GRP75 (1:1,000) antibodies.

Besides HCMV pUL37x1/vMIA, the hepatitis C virus (HCV) core protein is the only other viral protein known to target MAM subdomains (71). The HCV core protein, however, also accumulates in ER-tethered, cytosolic lipid droplets (4, 55, 89). It was suggested previously that cytosolic lipid droplets are derived from Sig-1R-circumscribed LRs of the MAM by the budding of the cytoplasmic leaflet (30, 32, 84). To test if pUL37x1/vMIA, like the HCV core protein, buds into cytoplasmic lipid droplets, we examined the colocalization of wt pUL37x1/vMIA tagged with yellow fluorescent protein (pUL37x1 wt1-163-YFP) with a cytosolic lipid droplet marker, Oil Red O dye (7, 38). pUL37x1 wt1-163-YFP did not detectably colocalize with the cytosolic lipid droplet marker (Fig. 1B). Analogously, Sig-1R, serving as a MAM control, did not detectably colocalize with Oil Red O.

Selective MβCD extraction of pUL37x1/vMIA from internal lipid rafts.Cholesterol is a critical scaffolding component of LR domains that is necessary to maintain the integrity of the LRs as a cohesive unit (35, 64). Its removal from membranes with drugs like MβCD leads to the dissolution of LRs. To identify the methanol-sensitive lipid domains containing pUL37x1/vMIA as authentic lipid rafts, we sought to reproduce the specific depletion of pUL37x1/vMIA from internal membranes using cholesterol extraction. To that end, HeLa cells were transiently transfected with pUL37x1 wt1-163-YFP and treated with MβCD either before or directly following cell lysis by sonication. Because MβCD does not permeate cellular membranes, treatment of whole cells dissolves only surface-exposed LRs on the plasma membrane (PM). After lysis, cells were subjected to subcellular fractionation and Western analyses to compare the abundances of pUL37x1 wt1-163-YFP in their ER/MAM and mitochondrial fractions. MβCD treatment dramatically reduced the pUL37x1 wt1-163-YFP abundance by 74% specifically from ER/MAMs when treatment occurred after cell lysis (compared to prelysis treatment control), consistent with the presence of pUL37x1/vMIA proteins in internal LRs of ER/MAM origin (Fig. 1C). Conversely, MβCD treatment did not detectably reduce pUL37x1 wt1-163-YFP levels (increased ∼62%) in mitochondrial membranes. These data concur with the results obtained by methanol extraction. MβCD treatment of lysed cells analogously reduced the Sig-1R-YFP abundance (decreased 55%), consistent with its known internal LR localization (28, 30, 32). In contrast, other MAM (FACL4 [decreased 9% to 11%]) and mitochondrial/MAM (GRP75 [increased 30%]) markers were minimally affected by MβCD treatment. Together, these data establish that pUL37x1/vMIA localizes to intracellular LRs, predominantly in ER/MAMs.

pUL37x1/vMIA NH2-terminal leader sequences mediate LR associations.To independently verify its association with LRs, we physically purified LRs from transiently transfected HeLa cells using flotation gradients. The tight packing of LRs enables them to strongly resist nonionic detergent solubilization at low temperatures, compared to surrounding nonraft membranes, which are readily solubilized (20, 68). HeLa cells expressing full-length, untagged pUL37x1/vMIA were treated with 1% Triton X-100 on ice and then layered at the bottom of a discontinuous sucrose gradient. Intact LRs, whose buoyant density caused them to float up to less dense sucrose layers from their original position, were purified in the upper fractions of the gradient. A portion of pUL37x1/vMIA was detected in DRMs (fraction 4), while the remaining pUL37x1/vMIA was detected in detergent-soluble fractions (non-DRMs), predictably localized in nonraft portions of the OMM or bulk ER, or in Triton X-100-solubilized ER LRs. The cholera toxin B subunit (CTB) was used to detect ganglioside GM1, a major component of plasma membrane LRs (26), in these whole-cell-derived DRMs. Also, Lyn, a cytosolic protein known to associate with LRs (41), was also partially detected in our collected DRM fractions. These results, while not directly differentiating the origin of observed LRs, resoundingly substantiate that pUL37x1/vMIA can associate with LRs during transient transfection.

pUL37x1/vMIA NH2-terminal MTS residues (aa 1 to 34), including a low-hydropathy leader, 21SY, and PRD, are necessary and sufficient to dictate its sequential trafficking through the ER and MAM to mitochondria (27, 45, 88). To determine if this leader sequence is also sufficient for LR associations, LRs were isolated from HeLa cells expressing pUL37x1/vMIA MTS fused to YFP (Fig. 2 B). pUL37x1 wt1-36-YFP was detected in DRM fractions of a sucrose flotation gradient. The presence of GM1 in these DRMs (fractions 3 and 4) was verified by the reactivity of CTB. Conversely, a nonraft inner mitochondrial membrane (IMM) marker, DsRed1-mito, was completely solubilized and not detected in the DRM fractions. These results establish that the pUL37x1/vMIA MTS, which dictates the protein's sequential trafficking, suffices for its LR association. Roughly half of the residues within the MTS are predicted to be imbedded within the lipid bilayer of ER, MAM, or mitochondrial membranes (47, 87, 88).

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

(A) Detection of HCMV pUL37x1/vMIA in purified LRs. HeLa cells were transfected with a vector (p327) expressing untagged pUL37x1 (14) and harvested 36 h after transfection. LRs were isolated by extraction with 1% Triton X-100 on ice and flotation in discontinuous sucrose gradients as previously described (12, 79). Twelve fractions (1 ml) were collected from the top of the gradient, and aliquots (30 μl) of each fraction were subjected to SDS-PAGE and Western analysis with anti-UL37x1 (1:2,500) and anti-Lyn (1:250) antibodies. For GM1 detection, aliquots of each fraction (2 μl) were spotted directly onto the nitrocellulose membrane and reacted with horseradish peroxidase-labeled CTB protein (Sigma), followed by ECL detection. (B) The UL37x1 MTS permits its LR association. HeLa cells were transfected with expression vectors encoding pUL37x1 wt1-36-YFP or DsRed1-mito. Twenty four hours later, whole cells were either treated with 1 μg/ml CTB (Molecular Probes) or left untreated prior to harvesting. LRs were isolated by Triton X-100 extraction on ice and flotation gradients as described above (A). Twenty microliters of each fraction was then separated by SDS-PAGE and subjected to Western analyses using anti-UL37x1 (1:2,500), anti-CTB (1:200), or anti-DsRed1-mito (1:2,000) antibodies.

Recently, detergent-specific disparities in LR extractions have been identified, dependent upon the identity of the subcellular membrane in which the LR is incident (44). As a result, LRs from intracellular membranes are more resistant to solubilization by Triton X-114 detergent than Triton X-100 extraction, to which LRs from the plasma membrane are more resistant (44). For experimental rigor, we repeated our LR extractions using 1% Triton X-114 solubilization of HeLa cells transiently transfected with pUL37x1/vMIA (Fig. 3 A). Indeed, pUL37x1/vMIA was detected at higher levels in DRMs from Triton X-114-treated cells than in those from Triton X-100-treated cells (Fig. 3B). These results are consistent with the association of pUL37x1/vMIA with internal LRs.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

(A) Detection of pUL37x1/vMIA in DRM following Triton X-114 extraction. HeLa cells were transfected with a vector expressing pUL37x1 wt1-163-YFP or YFP, extracted with 1% Triton X-114 on ice, and isolated by flotation gradients. Twenty microliters of each gradient fraction was separated by SDS-PAGE and analyzed by Western analysis using anti-UL37x1 (1:2,500) antiserum or anti-GFP/YFP (1:200) antibody. (B) Increased detection of HCMV pUL37x1/vMIA in DRMs in Triton X-114-extracted compared to Triton X-100-extracted DRMs. HeLa cells were transfected as described above (A) and extracted in parallel with 1% Triton X-100. Equal aliquots of the gradient fractions (fractions 1 to 4) containing DRMs following extraction with 1% Triton X-100 (left) and 1% Triton X-114 (right) were resolved by SDS-PAGE in parallel and analyzed for the presence of pUL37x1/vMIA as described above (A).

pUL37x1/vMIA is associated with ER/MAM LRs.To unambiguously verify whether pUL37x1/vMIA is associated with internal LRs in the ER/MAM or mitochondria, these organelles were first purified from HeLa cells expressing pUL37x1/vMIA. DRMs were then isolated from the purified fractions, and the presence of pUL37x1/vMIA in the DRMs was examined (Fig. 4). pUL37x1/vMIA was detected in DRMs from ER/MAM fractions but not in DRMs from mitochondrial fractions. The MAM LR marker Sig-1R showed a similar association with DRM from ER/MAM but not with DRM from mitochondria. Erlin 2, a known ER LR marker (11), served to verify the ER/MAM gradient fractions containing DRMs. Conversely, mitochondrial prohibitin (53) was detected in the DRM fractions obtained from purified mitochondria. These results establish that HCMV pUL37x1/vMIA is partially associated with LRs within the ER/MAM but not in mitochondria. Furthermore, they are consistent with the results described above showing methanol and MβCD extraction of pUL37x1/vMIA from ER/MAM but not mitochondrial fractions.

FIG. 4.
  • Open in new tab
  • Download powerpoint
FIG. 4.

pUL37x1 associates with internal LRs. HeLa cells were transfected with a vector expressing untagged pUL37x1 wt1-163 (p327). Thirty-six hours later, the ER/MAM and mitochondria were isolated as previously described (8, 9). LRs were then isolated from the purified subcellular fractions by cold 1% Triton X-100 extraction and flotation in sucrose gradients as described in the legend of Fig. 2A and as described previously (12, 79). Each gradient fraction (20 μl) was resolved by SDS-PAGE and analyzed by Western blotting using anti-UL37x1 (1:2,500), anti-Sig-1R (1:200), anti-erlin 2 (1:500), or anti-prohibitin (1:200) antibody.

pUL37x1/vMIA is LR associated throughout HCMV infection.To determine if pUL37x1/vMIA associates with LRs during infection, DRMs from HCMV-infected HFFs were examined at all temporal phases for pUL37x1/vMIA (Fig. 5 A). pUL37x1/vMIA was detected in DRMs isolated from HCMV-infected HFFs but not uninfected HFFs at IE (12 h postinfection [hpi]), early (24 hpi), and late (48 hpi and 72 hpi) times of infection. At IE and early times of infection, the buoyant density of DRMs with which pUL37x1/vMIA is associated is similar to that of transfected cells. At later times of infection (48 hpi and 72 hpi), the buoyant densities of pUL37x1/vMIA DRMs appear to change and are more broadly distributed. The presence of Lyn, a known LR marker protein, verified the identities of the DRM fractions from uninfected and HCMV-infected HFFs (Fig. 5B). These results suggest that HCMV pUL37x1/vMIA associates with LRs throughout infection and validate its LR association in transfected cells. These results further suggest that HCMV infection progressively alters the proteome composition of internal LRs and thereby alters their buoyant densities.

FIG. 5.
  • Open in new tab
  • Download powerpoint
FIG. 5.

pUL37x1/vMIA is LR associated throughout HCMV infection. HFFs were uninfected (left) or HCMV infected (BADwt at an MOI of 3) (right) and harvested at the indicated times after infection. LRs were isolated as described in the legend of Fig. 2. Fifteen microliters of each gradient fraction was resolved by SDS-PAGE and subjected to Western analysis using anti-UL37x1 antiserum (1:2,500) (A) or anti-Lyn antibody (1:250) (B).

Mapping of pUL37x1/vMIA MTS residues required for its LR association.The HCMV UL37x1 NH2-terminal MTS is sufficient to associate proteins with LRs (Fig. 2). The pUL37x1/vMIA MTS is a bipartite leader with a weakly hydrophobic leader (MTSα) needed for ER translocation and mitochondrial import as well as proximal downstream sequences (MTSβ), which regulate mitochondrial import (27, 45, 88). To determine which MTS residues are required for LR associations, we examined pUL37x1/vMIA MTS mutants for the ability to associate with LRs (Fig. 6 A). The pUL37x1 HH mutant has a greatly increased MTSα hydropathy score and is preferentially retained in the secretory apparatus and blocked in OMM import (88). Despite this trafficking defect, both the full-length (HH1-163-YFP) and leader (HH1-36-YFP) fusion proteins partially associated with DRMs (Fig. 6B). Similarly, both the full-length (LH1-163-YFP) and leader (LH1-36-YFP) fusion proteins of mutants with marginal hydropathy scores (which are known to retain the ability for sequential trafficking to the OMM) also associated with DRMs (Fig. 6C). A pUL37x1-Tom20 leader chimera, which has the Tom20 leader in place of the pUL37x1/vMIA leader, retained the ability to associate with DRMs, as did the parental pUL37x1 wt1-36-YFP control (Fig. 6D). Finally, a pUL37x1/vMIA MTSβ proline-rich-domain mutant (PRD1-36-YFP), which traffics preferentially to the OMM (88), associated with DRMs. Controls included the binding of CTB to verify the presence of ganglioside GM1 in the LR fractions (21) and the IMM marker DsRed1-mito, which was solubilized and retained in the non-DRM fractions. Some variation in the total abundances of wt and MTS mutants was observed for these and previous (88) experiments, suggesting differences in overall protein stability. To quantify this variability, total cell lysates (40 μg) from HeLa cells transfected with either pUL37x1 wt1-36-YFP or the MTS mutants were compared side by side using densitometry of a Western blot probed with mouse anti-GFP/YFP antibodies (data not shown). By calculating the MTS mutant abundances as percentages of the pUL37x1 wt1-36-YFP total protein, they could be arranged from highest to lowest in total protein amounts as follows: HH1-36-YFP (87%), HH1-163-YFP (70%), PRD1-36-YFP (37%), pUL37x1-Tom20 leader chimera (24%), LH1-163-YFP (13%), and LH1-36-YFP (9%). Importantly, while total protein abundances of the wt and MTS mutants differed, the efficiency in the lipid raft targeting of detected proteins appeared to be similar. These results establish that pUL37x1/vMIA domains which explicitly guide sequential trafficking to mitochondrial membranes are not required for the pUL37x1/vMIA LR association.

FIG. 6.
  • Open in new tab
  • Download powerpoint
FIG. 6.

pUL37x1 trafficking mutants do not block its association with LRs. (A) UL37x1 wt and mutant MTS sequences. Shown on the top are wt MTSα (aa 4 to 22) and MTSβ (aa 23 to 36). The hydrophobic leader is enclosed by the box. The mutant sequences are indicated by the arrowheads and boldface type. In UL37x1-Tom20 B, the Tom20 leader replaces UL37x1 MTSα. The predicted hydrophobicity scores (grand average of hydropathicity [GRAVY], Kyte-Doolittle scale) were calculated for the boxed residues of the wt and the LH mutant using the ProtParam application of the ExPASy proteomics server. (B to D) HeLa cells were transfected with expression vectors for HH1-163-YFP, HH1-36-YFP, wt1-36-YFP, or YFP (B); LH1-163-YFP, LH1-36-YFP, or YFP (C); or wt1-36-YFP, UL37x1-Tom20 B1-36-YFP, PRD1-36-YFP, YFP, or DsRed1-mito (D). Triton X-100-resistant LRs were extracted on ice from HeLa cells and enriched by flotation in discontinuous sucrose gradients as described in the legend of Fig. 2A and as previously described (12, 79). Twelve fractions (1 ml) were collected from the top to the bottom of the gradients. Equal volumes (30 μl) were resolved by PAGE and examined by Western analyses using anti-UL37x1, anti-Lyn, anti-GFP/YFP, anti-CTB, or anti-DsRed1-Mito antibodies.

The CBD motif in the HCMV UL37x1 MTS affects its LR association.Cholesterol is a major component of LRs, and the MAM is a cholesterol-rich subdomain of the ER (28). Consensus cholesterol binding domains (CBDs), defined as L/V-X1-5-Y-X1-5-K/R, in the benzodiazepine receptor (36) and Sig-1R (59) were recently characterized. We found a consensus CBD in the HCMV pUL37x1/vMIA MTS, spanning the predicted membrane-cytoplasm interface (Fig. 7). Moreover, the CBD is retained in primate CMV pUL37x1/vMIA leaders, suggesting its importance for evolutionarily conserved pUL37x1/vMIA function. These conserved domains are all positioned at the boundary of predicted α-helical regions, near the membrane interface, as required for functional folding (36). Tellingly, the chimpanzee CMV (CCMV) pUL37x1/vMIA homologue contains two overlapping CBDs.

FIG. 7.
  • Open in new tab
  • Download powerpoint
FIG. 7.

The pUL37x1 association with LRs is cholesterol binding dependent. (A) Conservation of the UL37x1 CBD in primate CMVs. The consensus CBDs (L/V-X1-5-Y-X1-5-R/K) in HCMV, chimpanzee CMV (CCMV), rhesus monkey CMV (RhCMV), and African green monkey CMV (AgmCMV) UL37x1 MTSs are indicated by parentheses and boldface type. The mutant sequences in HCMV CBD I and CBD II are indicated by the arrowheads and boldface type. (B) The consensus cholesterol binding site supports lipid raft targeting of pUL37x1. HeLa cells were transfected with vectors expressing pUL37x1 wt1-36-YFP, CBD I1-36-YFP, CBD II1-36-YFP, or YFP. Twenty-four hours later, cells were harvested and LRs were isolated by Triton X-100 extraction on ice and flotation on sucrose gradients as described in the legend of Fig. 2A. Twenty microliters of each fraction was separated by SDS-PAGE and analyzed by Western blotting using mouse anti-GFP/YFP (1:200). (C) Colocalization of CBD I1-36-YFP and CBD II1-36-YFP with DsRed1-mito. HFFs were transiently cotransfected with vectors expressing CBD I1-36-YFP, CBD II1-36-YFP, or wt1-36-YFP (green) and DsRed1-mito (red). Cells were methanol fixed at 24 h after transfection and then imaged by confocal microscopy. The panels on the left and center are grayscale. The panels on the right are the color overlay. (D) The CBD I1-36 mutant traffics to mitochondria. HeLa cells were transiently transfected with vectors expressing wt1-36-YFP, CBD I1-36-YFP, or YFP. Twenty-four hours after transfection, cells were harvested, and ER/MAM and mitochondrial fractions were isolated as previously described (8). Twenty micrograms of the purified fractions was resolved by SDS-PAGE and analyzed by Western blotting using anti-GFP/YFP (1:200), anti-DPM1 (1:100), and anti-GRP75 (1:1,000) antibodies.

The pUL37x1/vMIA mutants described above (Fig. 6) retained a consensus CBD in their NH2-terminal α-helix sequences. The chimeric pUL37x1-Tom20 leader chimera serendipitously created a consensus CBD sequence from the Tom20 leader (16L and 20Y) and the pUL37x1/vMIA MTSβ (25R).

To determine if affinity for cholesterol plays a role in the pUL37x1/vMIA association with LRs, we mutated the key tyrosine residue to alanine (Y19A) within the pUL37x1/vMIA CBD (CBD I1-36-YFP) and examined its ability to associate with LRs (Fig. 7B). CBD I1-36-YFP was markedly reduced in its association with DRMs (decreased 93% compared to the wt), as detected by flotation gradients. An additional mutation in the pUL37x1/vMIA CBD site (CBD II1-36-YFP) was further reduced (decreased 99% compared to the wt) in its LR association. From these results, we conclude that pUL37x1/vMIA CBD mediates, at least in part, the LR association.

LRs can regulate the trafficking of some proteins. To determine whether the pUL37x1 CBD I1-36-YFP and CBD II1-36-YFP mutants, which are defective in LR associations, are also defective in trafficking, we examined their colocalization with DsRed1-mito using confocal microscopy (Fig. 7C). Both CBD I1-36-YFP and CBD II1-36-YFP partially colocalized with DsRed1-mito (Clontech), suggesting their ability to traffic to mitochondria. To independently verify trafficking to mitochondria, HeLa cells expressing CBD I1-36-YFP, control wt1-36-YFP, or YFP alone were fractionated into ER/MAM and mitochondrial fractions (Fig. 7D). CBD I1-36-YFP was detected in proportion in the ER/MAM and mitochondrial fractions, comparable to those observed for wt1-36-YFP. The use of ER (DPM1) and MAM/mitochondrial (GRP75) markers verified the identity and purity of the fractions. Similarly, CBD II1-36-YFP trafficking to mitochondria was comparable to that of the wt protein, as detected by subcellular fractionation (C. D. Williamson and A. M. Colberg-Poley, unpublished results). These results demonstrate the ability of CBD mutants to traffic to mitochondria despite their notable reduction in LR associations. This finding substantiates that the LR association does not dictate pUL37x1/vMIA sequential trafficking to the OMM and suggests another functional consequence for the LR association of these proteins.

DISCUSSION

HCMV pUL37x1/vMIA sequentially traffics from the ER to the MAM, an ER subdomain rich in lipid synthetic enzymes and critical cellular calcium signaling complexes, and then to the outer mitochondrial membrane (9, 10, 28, 88). Here, we report that pUL37x1/vMIA associates with cholesterol-rich DRMs in the ER/MAM of transfected cells and of HCMV-infected cells. Surprisingly, we found this LR association to be independent of mitochondrial targeting sequences but dependent upon its ability to bind cholesterol conferred by the CBD within the UL37x1 MTS.

The compartmentalization of membrane-associated proteins into discrete subdomains, known as lipid rafts, for specific functions and signaling pathways at the plasma membrane has been well characterized (42). It is now increasingly clear that lipid rafts can also form inside the cell, particularly in the ER (11, 28, 32, 34, 44). A unique characteristic of the MAM is the enrichment of DRM-forming lipids (ceramide and cholesterol), the levels of which are lower in bulk ER (28). Sig-1R is highly compartmentalized in LRs in the MAM (32). Our results suggest that HCMV pUL37x1/vMIA, partially localized in the MAM, also associates with internal lipid rafts therein. The experimental evidence supporting this conclusion includes its selective MβCD extraction from lysed cells, thus establishing the internal nature of these LRs. A similar MβCD extraction was observed in our hands with the known MAM LR protein Sig-1R (28). Furthermore, upon the fractionation of the extracted lysates, we found a selective reduction of the pUL37x1/vMIA abundance in ER/MAM fractions but not mitochondrial fractions, underscoring the localization of the LRs within the ER/MAMs. Because MAM subdomains are the primary ER sites of confluence of lipid raft components, we observe pUL37x1/vMIA in close proximity to the MAM lipid raft constituent Sig-1R, and because we rarely observed a broad distribution of wt pUL37x1/vMIA proteins in ER sites outside MAM domains by confocal microscopy, we conclude that pUL37x1/VMIA-containing lipid rafts most likely reside within the MAM. We independently verified the MβCD results by directly isolating detergent-resistant membranes (DRMs) from subcellular fractions of transfected cells. Consistent with our previous results, we found that pUL37x1/vMIA-associated DRMs were isolated from ER/MAM fractions but not from mitochondrial fractions. Finally, the pattern of resistance to detergent extraction showed that pUL37x1/vMIA LRs are more resistant to Triton X-114 solubilization than to Triton X-100. These findings support their identity as internal LRs (44) and are analogous to the higher resistance of Sig-1R MAM LRs to Triton X-114 solubilization (28). Combined, our results argue that pUL37x1/vMIA localizes to intracellular LRs in MAMs.

We verified the presence of pUL37x1/vMIA in DRMs during HCMV infection. In fact, the association of pUL37x1/vMIA with LRs was observed throughout infection. The persistence of this association throughout infection suggests its importance in the function of pUL37x1/vMIA during various temporal phases of lytic replication. Nonetheless, it is noteworthy that HCMV infection appears to dynamically change the buoyant density of the DRMs with which pUL37x1/vMIA associates. This result suggests that HCMV infection alters the proteome composition of LRs. Indeed, we are accumulating proteomic data directly measuring such HCMV-induced changes in the LR proteome (A. Zhang et al., unpublished results). Thus, it appears that HCMV infection specifically targets the MAM and lipid rafts therein to facilitate productive infection, possibly in an effort to regulate ER-mitochondrial communication that might be detrimental to HCMV replication.

Because LRs can regulate protein sorting (75, 76), we examined whether pUL37x1/vMIA sequential trafficking to mitochondria requires its LR association. Surprisingly, it does not. The mutation of the UL37x1 MTS required for its sequential trafficking to the OMM, including its moderate-hydropathy leader, 21SY, and PRD (88) motifs, was dispensable for its LR association. This is based upon the findings that UL37x1 MTS mutants defective in trafficking to mitochondria were unimpeded in their ability to associate with LRs. In contrast, the LR association of Sig-1R, which has two CBDs in close proximity to one of its transmembrane domains (59), anchors it in the MAM (28). The disruption of ceramide synthesis or LR integrity causes Sig-1R to relocalize from the MAM LRs to ER cisternae.

The LR association of pUL37x1/vMIA is, however, dependent upon cholesterol binding, as the mutation of its consensus CBD, spanning the C terminus of its uncleaved hydrophobic leader sequence (MTSα), reduced its association with LRs. The UL37x1 MTS CBD appears to be evolutionarily important for pUL37x1/vMIA function, as the consensus CBDs are conserved in all primate CMV UL37x1 MTSs. Tellingly, mutants in the consensus UL37x1 MTS CBD (19Y and 23R) trafficked similarly to the wt protein. Our results suggest that the pUL37x1/vMIA association with MAM LRs is not required and is not sufficient for mitochondrial import. This is underscored by the phenotype of the pUL37x1/vMIA HH mutant, which traffics into the MAM and to LRs but yet is defective in mitochondrial import.

Because of the phenotypes of multiple pUL37x1/vMIA mutants, we conclude that the UL37x1 targeting signals for sequential trafficking and for LR associations are independent. This independence suggests that the LR association, while occurring in the MAM, is not required for its sequential trafficking from the ER to mitochondria. This further suggests that pUL37x1/vMIA is associated with LRs as an endpoint with important functions therein and not as an intermediate required for its trafficking to the OMM.

By its trafficking into the MAM and its internal LRs, pUL37x1/vMIA is well positioned therein to regulate cross talk between the ER and mitochondria to promote cell survival. One of the known functions of the MAM is to regulate Ca2+ signaling from the ER to mitochondria (29). Sig-1R, localized predominantly in MAM LRs (28), stabilizes the conformation of IP3R3, thus regulating Ca2+ signaling from the ER to mitochondria (31). IP3R was recently found to partially localize to MAM LRs (28). HCMV pUL37x1/vMIA causes an efflux of Ca2+ from the ER (72). We have further evidence that the levels of MAM calcium signaling complex, including GRP75 and VDAC, are increased during HCMV infection (10; Zhang et al., unpublished). Additionally, LRs are increasingly being appreciated as sites for the assembly of apoptosome components (22). The presence of pUL37x1/vMIA in MAM LRs may allow HCMV infection to affect the assembly of apoptosome components therein.

MAM LRs are enriched in cholesterol, sphingolipids, and ceramide (28). Regulation by Sig-1R is thought to induce the export of cholesterol from the ER to the PM (32). HCMV infection is known to regulate the synthesis of sphingolipids, including ceramide, cholesterol, and fatty acids (43, 57, 70). De novo-synthesized ceramide can be transferred from the MAM to the OMM and result in mitochondrion-initiated apoptosis (80). HCMV may regulate the export of these bioactive lipids to effectively block proapoptotic signals or regulate signaling. This could predictably have important consequences not only for regulating infection but also for HCMV disease phenotypes. Congenital HCMV infection is associated predominantly with neurological sequelae (54). The human brain holds nearly 25% of the body's cholesterol and cholesterol derivatives (18), and lipid rafts have been reported to be critical for its normal functioning (17, 23, 39). Thus, pUL37x1/vMIA, by virtue of its cholesterol binding and lipid raft association, may play unique or uniquely significant roles within brain tissues.

ACKNOWLEDGMENTS

We are grateful to Peiying Yu for her advice on lipid raft purification using flotation gradients and to Stephen Robbins for the kind gift of anti-erlin 2 antiserum.

The studies were funded in part by NIH R01 AI057906 and by bridge funds from the Children's Research Institute to A.M.C.-P. The confocal microscopy imaging was supported by a core grant (1P30HD40677) to the Children's Intellectual and Developmental Disabilities Research Center.

FOOTNOTES

    • Received 27 August 2010.
    • Accepted 14 December 2010.
    • Accepted manuscript posted online 22 December 2010.
  • Copyright © 2011, American Society for Microbiology

REFERENCES

  1. 1.↵
    Adair, R., G. W. Liebisch, Y. Su, and A. M. Colberg-Poley. 2004. Alteration of cellular RNA splicing and polyadenylation machineries during productive human cytomegalovirus infection. J. Gen. Virol. 85:3541-3553.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Al-Barazi, H. O., and A. M. Colberg-Poley. 1996. The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus. J. Virol. 70:7198-7208.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Arnoult, D., et al. 2004. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. U. S. A. 101:7988-7993.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Barba, G., et al. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. U. S. A. 94:1200-1205.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Biegalke, B. J. 1999. Human cytomegalovirus US3 gene expression is regulated by a complex network of positive and negative regulators. Virology 261:155-164.
    OpenUrlCrossRefPubMed
  6. 6.
    Bionda, C., J. Portoukalian, D. Schmitt, C. Rodriguez-Lafrasse, and D. Ardail. 2004. Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem. J. 382:527-533.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Bostrom, P., et al. 2005. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 25:1945-1951.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Bozidis, P., C. D. Williamson, and A. M. Colberg-Poley. 2007. Isolation of endoplasmic reticulum, mitochondria, and mitochondria-associated membrane fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts. Curr. Protoc. Cell Biol. 3:3.27.
    OpenUrl
  9. 9.↵
    Bozidis, P., C. D. Williamson, and A. M. Colberg-Poley. 2008. Mitochondrial and secretory human cytomegalovirus UL37 proteins traffic into mitochondrion-associated membranes of human cells. J. Virol. 82:2715-2726.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Bozidis, P., C. D. Williamson, D. S. Wong, and A. M. Colberg-Poley. 2010. Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection. J. Virol. 84:7898-7903.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Browman, D. T., M. E. Resek, L. D. Zajchowski, and S. M. Robbins. 2006. Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J. Cell Sci. 119:3149-3160.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Carman, C. V., M. P. Lisanti, and J. L. Benovic. 1999. Regulation of G protein-coupled receptor kinases by caveolin. J. Biol. Chem. 274:8858-8864.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Colberg-Poley, A. M., M. B. Patel, D. P. Erezo, and J. E. Slater. 2000. Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria. J. Gen. Virol. 81:1779-1789.
    OpenUrlPubMedWeb of Science
  14. 14.↵
    Colberg-Poley, A. M., L. D. Santomenna, P. P. Harlow, P. A. Benfield, and D. J. Tenney. 1992. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J. Virol. 66:95-105.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    de Brito, O. M., and L. Scorrano. 2009. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. Mitochondrion 9:222-226.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    de Brito, O. M., and L. Scorrano. 2008. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456:605-610.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Debruin, L. S., and G. Harauz. 2007. White matter rafting—membrane microdomains in myelin. Neurochem. Res. 32:213-228.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Dietschy, J. M., and S. D. Turley. 2004. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45:1375-1397.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Dunn, W., et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    El Kirat, K., and S. Morandat. 2007. Cholesterol modulation of membrane resistance to Triton X-100 explored by atomic force microscopy. Biochim. Biophys. Acta 1768:2300-2309.
    OpenUrlPubMed
  21. 21.↵
    Fishman, P. H. 1982. Role of membrane gangliosides in the binding and action of bacterial toxins. J. Membr. Biol. 69:85-97.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Gajate, C., F. Gonzalez-Camacho, and F. Mollinedo. 2009. Lipid raft connection between extrinsic and intrinsic apoptotic pathways. Biochem. Biophys. Res. Commun. 380:780-784.
    OpenUrlCrossRefPubMed
  23. 23.↵
    Gielen, E., et al. 2006. Rafts in oligodendrocytes: evidence and structure-function relationship. Glia 54:499-512.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Goldmacher, V. S. 2004. Cell death suppressors encoded by cytomegalovirus. Prog. Mol. Subcell. Biol. 36:1-18.
    OpenUrlCrossRefPubMed
  25. 25.↵
    Goldmacher, V. S., et al. 1999. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 96:12536-12541.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    Harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929-942.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    Hayajneh, W. A., et al. 2001. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology 279:233-240.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Hayashi, T., and M. Fujimoto. 2010. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction. Mol. Pharmacol. 77:517-528.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Hayashi, T., R. Rizzuto, G. Hajnoczky, and T. P. Su. 2009. MAM: more than just a housekeeper. Trends Cell Biol. 19:81-88.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    Hayashi, T., and T. P. Su. 2005. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci. 77:1612-1624.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Hayashi, T., and T. P. Su. 2007. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131:596-610.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    Hayashi, T., and T. P. Su. 2003. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J. Pharmacol. Exp. Ther. 306:718-725.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Hayashi, T., and T. P. Su. 2004. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 101:14949-14954.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    Hoegg, M. B., D. T. Browman, M. E. Resek, and S. M. Robbins. 2009. Distinct regions within the erlins are required for oligomerization and association with high molecular weight complexes. J. Biol. Chem. 284:7766-7776.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    Ilangumaran, S., and D. C. Hoessli. 1998. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem. J. 335(Pt. 2):433-440.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    Jamin, N., et al. 2005. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19:588-594.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    Jurak, I., and W. Brune. 2006. Induction of apoptosis limits cytomegalovirus cross-species infection. EMBO J. 25:2634-2642.
    OpenUrlCrossRefPubMed
  38. 38.↵
    Kinkel, A. D., et al. 2004. Oil red-O stains non-adipogenic cells: a precautionary note. Cytotechnology 46:49-56.
    OpenUrlCrossRefPubMed
  39. 39.↵
    Korade, Z., and A. K. Kenworthy. 2008. Lipid rafts, cholesterol, and the brain. Neuropharmacology 55:1265-1273.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Kouzarides, T., A. T. Bankier, S. C. Satchwell, E. Preddy, and B. G. Barrell. 1988. An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein. Virology 165:151-164.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    Lang, M. L., L. Shen, and W. F. Wade. 1999. Gamma-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor Fc alpha R. J. Immunol. 163:5391-5398.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Lingwood, D., and K. Simons. 2010. Lipid rafts as a membrane-organizing principle. Science 327:46-50.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    Machesky, N. J., et al. 2008. Human cytomegalovirus regulates bioactive sphingolipids. J. Biol. Chem. 283:26148-26160.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    Marwali, M. R., J. Rey-Ladino, L. Dreolini, D. Shaw, and F. Takei. 2003. Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity. Blood 102:215-222.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    Mavinakere, M. S., and A. M. Colberg-Poley. 2004. Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection. J. Gen. Virol. 85:323-329.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    Mavinakere, M. S., and A. M. Colberg-Poley. 2004. Internal cleavage of the human cytomegalovirus UL37 immediate-early glycoprotein and divergent trafficking of its proteolytic fragments. J. Gen. Virol. 85:1989-1994.
    OpenUrlCrossRefPubMed
  47. 47.↵
    Mavinakere, M. S., C. D. Williamson, V. S. Goldmacher, and A. M. Colberg-Poley. 2006. Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation. J. Virol. 80:6771-6783.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Maxfield, F. R. 2002. Plasma membrane microdomains. Curr. Opin. Cell Biol. 14:483-487.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    McCormick, A. L., L. Roback, D. Livingston-Rosanoff, and C. St. Clair. 2010. The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J. Virol. 84:5108-5123.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    McCormick, A. L., L. Roback, and E. S. Mocarski. 2008. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog. 4:e1000063.
    OpenUrlCrossRefPubMed
  51. 51.↵
    McCormick, A. L., V. L. Smith, D. Chow, and E. S. Mocarski. 2003. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J. Virol. 77:631-641.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    Mendes, C. C., et al. 2005. The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J. Biol. Chem. 280:40892-40900.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    Merkwirth, C., and T. Langer. 2009. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 1793:27-32.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    Mocarski, E. S., T. Shenk, and R. F. Pass. 2007. Cytomegaloviruses, p. 2701-2772. In D. M. Knipe et al. (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
    OpenUrl
  55. 55.↵
    Moradpour, D., C. Englert, T. Wakita, and J. R. Wands. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Mukherjee, S., and F. R. Maxfield. 2004. Membrane domains. Annu. Rev. Cell Dev. Biol. 20:839-866.
    OpenUrlCrossRefPubMedWeb of Science
  57. 57.↵
    Munger, J., et al. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26:1179-1186.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    Norris, K. L., and R. J. Youle. 2008. Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins. J. Virol. 82:6232-6243.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    Palmer, C. P., R. Mahen, E. Schnell, M. B. Djamgoz, and E. Aydar. 2007. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res. 67:11166-11175.
    OpenUrlAbstract/FREE Full Text
  60. 60.↵
    Pauleau, A.-L., et al. 2007. Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA. Oncogene 26:7067-7080.
    OpenUrlCrossRefPubMed
  61. 61.↵
    Pizzo, P., and T. Pozzan. 2007. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol. 17:511-517.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    Poncet, D., et al. 2004. An anti-apoptotic viral protein that recruits Bax to mitochondria. J. Biol. Chem. 279:22605-22614.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    Poncet, D., et al. 2006. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J. Cell Biol. 174:985-996.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    Popik, W., T. M. Alce, and W. C. Au. 2002. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol. 76:4709-4722.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    Reboredo, M., R. F. Greaves, and G. Hahn. 2004. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol. 85:3555-3567.
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    Reeves, M. B., A. A. Davies, B. P. McSharry, G. W. Wilkinson, and J. H. Sinclair. 2007. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316:1345-1348.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    Reid, G. G., V. Ellsmore, and N. D. Stow. 2003. An analysis of the requirements for human cytomegalovirus oriLyt-dependent DNA synthesis in the presence of the herpes simplex virus type 1 replication fork proteins. Virology 308:303-316.
    OpenUrlCrossRefPubMed
  68. 68.↵
    Rietveld, A., and K. Simons. 1998. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta 1376:467-479.
    OpenUrlCrossRefPubMed
  69. 69.↵
    Rusiñol, A. E., Z. Cui, M. H. Chen, and J. E. Vance. 1994. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269:27494-27502.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    Sanchez, V., and J. J. Dong. 2010. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology 404:71-77.
    OpenUrlCrossRefPubMed
  71. 71.↵
    Schwer, B., et al. 2004. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol. 78:7958-7968.
    OpenUrlAbstract/FREE Full Text
  72. 72.↵
    Sharon-Friling, R., J. Goodhouse, A. M. Colberg-Poley, and T. Shenk. 2006. Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores. Proc. Natl. Acad. Sci. U. S. A. 103:19117-19122.
    OpenUrlAbstract/FREE Full Text
  73. 73.↵
    Shiao, Y. J., B. Balcerzak, and J. E. Vance. 1998. A mitochondrial membrane protein is required for translocation of phosphatidylserine from mitochondria-associated membranes to mitochondria. Biochem. J. 331(Pt. 1):217-223.
    OpenUrlAbstract/FREE Full Text
  74. 74.↵
    Simmen, T., et al. 2005. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J. 24:717-729.
    OpenUrlAbstract
  75. 75.↵
    Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
    OpenUrlCrossRefPubMedWeb of Science
  77. 77.↵
    Skaletskaya, A., et al. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. U. S. A. 98:7829-7834.
    OpenUrlAbstract/FREE Full Text
  78. 78.↵
    Smith, G., and E. S. Mocarski. 2005. Contribution of GADD45 family members to cell death suppression by cellular bcl-xL and cytomegalovirus vMIA. J. Virol. 79:14923-14932.
    OpenUrlAbstract/FREE Full Text
  79. 79.↵
    Song, K. S., et al. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271:15160-15165.
    OpenUrlAbstract/FREE Full Text
  80. 80.↵
    Stiban, J., L. Caputo, and M. Colombini. 2008. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 49:625-634.
    OpenUrlAbstract/FREE Full Text
  81. 81.↵
    Stone, S. J., and J. E. Vance. 2000. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J. Biol. Chem. 275:34534-34540.
    OpenUrlAbstract/FREE Full Text
  82. 82.↵
    Szabadkai, G., et al. 2006. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol. 175:901-911.
    OpenUrlAbstract/FREE Full Text
  83. 83.↵
    Szabadkai, G., and R. Rizzuto. 2004. Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood? FEBS Lett. 567:111-115.
    OpenUrlCrossRefPubMedWeb of Science
  84. 84.↵
    Tauchi-Sato, K., S. Ozeki, T. Houjou, R. Taguchi, and T. Fujimoto. 2002. The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition. J. Biol. Chem. 277:44507-44512.
    OpenUrlAbstract/FREE Full Text
  85. 85.↵
    Terhune, S., et al. 2007. Human cytomegalovirus UL38 protein blocks apoptosis. J. Virol. 81:3109-3123.
    OpenUrlAbstract/FREE Full Text
  86. 86.↵
    Vance, J. E. 1990. Phospholipid synthesis in a membrane fraction associated with mitochondria. J. Biol. Chem. 265:7248-7256.
    OpenUrlAbstract/FREE Full Text
  87. 87.↵
    Williamson, C. D., and A. M. Colberg-Poley. 2009. Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev. Med. Virol. 19:147-164.
    OpenUrlCrossRefPubMed
  88. 88.↵
    Williamson, C. D., and A. M. Colberg-Poley. 2010. Intracellular sorting signals for sequential trafficking of human cytomegalovirus UL37 proteins to the endoplasmic reticulum and mitochondria. J. Virol. 84:6400-6409.
    OpenUrlAbstract/FREE Full Text
  89. 89.↵
    Yasui, K., et al. 1998. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:6048-6055.
    OpenUrlAbstract/FREE Full Text
  90. 90.↵
    Yee, L. F., P. L. Lin, and M. F. Stinski. 2007. Ectopic expression of HCMV IE72 and IE86 proteins is sufficient to induce early gene expression but not production of infectious virus in undifferentiated promonocytic THP-1 cells. Virology 363:174-188.
    OpenUrlCrossRefPubMed
  91. 91.↵
    Yu, D., M. C. Silva, and T. Shenk. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401.
    OpenUrlAbstract/FREE Full Text
  92. 92.↵
    Zhao, Z., and Y. Xu. 2009. An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J. Lipid Res. 51:652-659.
    OpenUrlCrossRefPubMed
  93. 93.↵
    Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
The Human Cytomegalovirus Protein UL37 Exon 1 Associates with Internal Lipid Rafts
Chad D. Williamson, Aiping Zhang, Anamaris M. Colberg-Poley
Journal of Virology Feb 2011, 85 (5) 2100-2111; DOI: 10.1128/JVI.01830-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Human Cytomegalovirus Protein UL37 Exon 1 Associates with Internal Lipid Rafts
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Human Cytomegalovirus Protein UL37 Exon 1 Associates with Internal Lipid Rafts
Chad D. Williamson, Aiping Zhang, Anamaris M. Colberg-Poley
Journal of Virology Feb 2011, 85 (5) 2100-2111; DOI: 10.1128/JVI.01830-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514